Home
Categories
Add source
Login
Reuters
5 saat, 11 dakika
Samsung Biologics to buy U.S. drug production facility from GSK for $280 mln
Samsung Biologics to buy U.S. drug production facility from GSK for $280 mln
Go to News Site
Reuters